Anticoagulants in Cirrhosis: Main Concerns
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Eichholz J, Wedemeyer H, Maasoumy B
. The Challenge of Anticoagulation in Liver Cirrhosis. Visc Med. 2024; 39(6):169-176.
PMC: 10775854.
DOI: 10.1159/000535438.
View
2.
Campello E, Zanetto A, Bulato C, Maggiolo S, Spiezia L, Russo F
. Coagulopathy is not predictive of bleeding in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure. Liver Int. 2021; 41(10):2455-2466.
PMC: 8518681.
DOI: 10.1111/liv.15001.
View
3.
Sinha T, Kaur M, Mayow A, Soe T, Khreis K, Chaudhari S
. Effectiveness of Direct Oral Anticoagulants and Vitamin K Antagonists in Preventing Stroke in Patients With Atrial Fibrillation and Liver Cirrhosis: A Systematic Review and Meta-Analysis. Cureus. 2024; 16(6):e62606.
PMC: 11257023.
DOI: 10.7759/cureus.62606.
View
4.
Bechmann L, Sichau M, Wichert M, Gerken G, Kroger K, Hilgard P
. Low-molecular-weight heparin in patients with advanced cirrhosis. Liver Int. 2010; 31(1):75-82.
DOI: 10.1111/j.1478-3231.2010.02358.x.
View
5.
Turco L, de Raucourt E, Valla D, Villa E
. Anticoagulation in the cirrhotic patient. JHEP Rep. 2020; 1(3):227-239.
PMC: 7001584.
DOI: 10.1016/j.jhepr.2019.02.006.
View